Blood Preparation

Global Blood Preparation Market to Reach US$75.4 Billion by 2030

The global market for Blood Preparation estimated at US$53.0 Billion in the year 2024, is expected to reach US$75.4 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Whole Blood, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$35.2 Billion by the end of the analysis period. Growth in the Blood Derivatives segment is estimated at 6.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$13.7 Billion While China is Forecast to Grow at 9.4% CAGR

The Blood Preparation market in the U.S. is estimated at US$13.7 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$17.8 Billion by the year 2030 trailing a CAGR of 9.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.4% and 4.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Blood Preparation Market – Key Trends & Drivers Summarized

How is Blood Preparation Evolving in Modern Medicine?

Blood preparation is an essential aspect of modern medical treatment, involving the collection, processing, and storage of blood and its components for use in various therapeutic applications, including transfusions, surgeries, and treatments for blood disorders. The market for blood preparation is evolving rapidly due to advancements in blood component separation, storage technologies, and the development of blood substitutes. Blood preparation includes the processing of whole blood into components such as red blood cells, platelets, plasma, and clotting factors, which are used to treat a range of conditions, from trauma and surgeries to anemia, cancer, and hemophilia.

Technological innovations in blood preparation have significantly improved the safety, efficacy, and shelf life of blood products. For example, pathogen reduction technologies are being developed to improve the safety of blood transfusions by inactivating viruses, bacteria, and parasites in blood components. Furthermore, advancements in storage solutions and cryopreservation techniques are extending the shelf life of blood products, ensuring that they remain viable for longer periods, which is crucial for emergency situations and remote healthcare settings. These innovations are not only improving the availability of blood products but also reducing the risk of transfusion-related complications.

What Role Does Blood Preparation Play in Treating Blood Disorders?

Blood preparation is critical in the treatment of various blood disorders, including anemia, hemophilia, and leukemia. For patients with anemia, red blood cell transfusions are essential for replenishing the body’s oxygen-carrying capacity, especially in cases of severe blood loss, chronic diseases, or chemotherapy. In patients with clotting disorders such as hemophilia, blood preparation involves the extraction and concentration of clotting factors, particularly Factor VIII and Factor IX, which are essential for preventing and controlling bleeding episodes. These concentrated blood products can be administered to patients to restore normal clotting function, significantly improving their quality of life.

In the case of leukemia and other blood cancers, blood preparation is vital for both supportive care and treatment. Patients undergoing chemotherapy or radiation therapy often require platelet transfusions to prevent bleeding and plasma transfusions to manage clotting abnormalities. Additionally, stem cell transplants, which involve the infusion of healthy blood-forming cells, are an important therapeutic option for patients with certain types of blood cancers. The preparation of blood components for stem cell transplants ensures that patients receive the necessary support during their treatment journey, highlighting the importance of advanced blood processing techniques in modern medical care.

How is Blood Preparation Enhancing Surgical and Emergency Care?

In surgical and emergency care, blood preparation plays a pivotal role in saving lives and improving patient outcomes. During major surgeries, especially those involving significant blood loss, prepared blood components such as red blood cells, plasma, and platelets are often required to maintain the patient’s blood volume, support oxygen delivery, and prevent clotting disorders. The ability to quickly access and transfuse these blood products can make the difference between life and death in critical situations. Additionally, blood preparation is essential in trauma care, where rapid transfusions of blood components are necessary to stabilize patients with severe injuries and hemorrhages.

The development of advanced blood preparation techniques, including preoperative autologous blood donation, where patients donate their own blood before surgery, is enhancing patient safety by reducing the need for allogeneic (donor) blood transfusions. This minimizes the risk of transfusion-related complications such as immune reactions or infections. Furthermore, innovations in portable blood storage and preparation devices are improving the ability of emergency medical teams to provide life-saving transfusions in the field, particularly in remote or disaster-stricken areas. These advancements are enhancing the responsiveness and effectiveness of surgical and emergency care, ensuring that patients receive the critical blood products they need when and where they need them.

What Factors Are Driving the Growth of the Blood Preparation Market?

The growth of the blood preparation market is driven by several factors, including the increasing demand for blood products due to rising surgical procedures, trauma cases, and the growing prevalence of blood disorders. The expanding elderly population, which is more susceptible to chronic diseases and surgeries, is contributing to a higher demand for blood products, particularly red blood cells and platelets. In addition, advancements in blood component separation and storage technologies are improving the availability and safety of blood products, encouraging their use in a wider range of medical applications.

Regulatory support and increasing awareness about the importance of blood donation are also driving the market. Government initiatives aimed at improving blood donation infrastructure and ensuring the safety of the blood supply are contributing to the growth of the blood preparation market. The development of blood substitutes, which are designed to mimic the oxygen-carrying capacity of red blood cells, is another area of innovation that is expected to impact the market. While still in the research phase, these substitutes have the potential to address shortages of donated blood and provide alternatives for patients who are unable to receive traditional blood transfusions. Finally, the rising incidence of trauma cases, surgeries, and the growing prevalence of blood-related conditions are fueling the demand for blood preparation products globally.

SCOPE OF STUDY:

The report analyzes the Blood Preparation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product (Whole Blood, Blood Derivatives, Blood Components); Type (Anticoagulants, Platelet Aggregation Inhibitors, Fibrinolytics); Application (Thrombocytosis, Pulmonary Embolism, Angina Blood Vessel Complications, Renal Impairment, Other Applications)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 33 Featured) -

• AstraZeneca plc
• Baxter International Inc
• Bristol-Myers Squibb Company
• GlaxoSmithKline plc
• Leo Pharma A/S
• Pfizer, Inc
• Sanofi
• Xiamen Hisunny Chemical Co., LTD

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs CBob geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.